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Relaxant effect of Crocus sativus (saffron) on 
guinea-pig tracheal chains and its possible mechanisms 
M. H. Boskabady and M. R. Aslani 
Abstract 
As indicated in ancient Iranian medical books, Crocus sativus has therapeutic effects on respiratory
diseases. The relaxant effect of this plant has been observed also on smooth muscles in previous stud-
ies. Therefore, in this study the relaxant effects of aqueous-ethanolic extracts of C. sativus and one of
its main constituents, safranal, were examined on guinea-pig tracheal chains. The relaxant effects of
four cumulative concentrations of aqueous-ethanolic extract (0.15, 0.3, 0.45, and 0.60 g %) and
safranal (0.15, 0.30, 0.45, and 0.60 mL 0.2 mg mL−1 solution) in comparison with saline, as negative
control, and four cumulative concentrations of theophylline (0.15, 0.30, 0.45, and 0.60 mM), as posit-
ive control, were examined using guinea-pig precontracted tracheal chains. The tracheal chains had
been precontracted by three different methods. Group 1 had been precontracted using 10 mM metha-
choline. The other two groups had been precontracted using 60 mM KCl at two different conditions:
non-incubated tissues (group 2) and tissues incubated with 1 mM propranolol,1 mM chlorpheniramine
and 1 mM atropine (group 3) (for each group, n = 6). In group 1 all concentrations of theophylline,
extract and safranal showed significant relaxant effects compared with saline (P < 0.05 to P < 0.001).
In group 2 theophylline, extract and safranal showed concentration-dependent relaxant effects also
compared with saline (P < 0.05 to P < 0.001 for different concentrations except two low concentra-
tions of safranal). However, in group 3 the extracts of C. sativus showed a weak relaxant effect
(P < 0.05 only for the highest concentration). The effects of the last concentration of safranal (0.60 mL
0.2 mg mL−1 solution) in group 1, and all its concentrations in group 2 were significantly lower than
those of theophylline (P < 0.05 to P < 0.001). In addition, the effects of safranal 0.45 and 0.60 mL
0.2 mg mL−1 solution in groups 1 and 2 were significantly lower than that of C. sativus extract. There
were significant correlations between the relaxant effects and concentrations for extract, safranal
and theophylline in all experimental groups (P < 0.001 for all cases). These results showed a potent
relaxant effect of C. sativus on tracheal chains of guinea-pigs that was comparable to or even higher
than that of theophylline at the concentrations used. The results indicated that safranal was, at least
in part, responsible for the relaxant effect of C. sativus. 
Crocus sativus L, commonly known as saffron, is a small perennial plant from the iridaceae
family. It is cultivated in many places, but particularly in France, Spain, Sicily, and Iran. It
has green, hairy leaves approximately one to one-and-a-half feet long and a funnel-shaped,
reddish-purple flower. C. sativus is used in folk medicine as an antispasmodic, eupeptic,
gingival sedative, anticatarrhal, nerve sedative, carminative, diaphoretic, expectorant, stim-
ulant, stomachic, aphrodisiac and emmenagogue (Rios et al 1996). The stigma, also called
the style (central part of the flower, the female sexual organ), is the part of the plant used
medicinally. The main active constituents of this plant are picrocrocin and its derivatives
including safranal, flavonoid derivatives and crocin (Tarantilis et al 1995). 
Previous studies have shown different pharmacological effects for this plant including
anticonvulsant (Hosseinzadeh & Khosravan 2002), antidepressant (Hosseinzadeh et al 2004),
anti-inflammatory (Hosseinzadeh & Younesi 2002), antioxidant effect (Abe et al 1999), anti-
tumour and radical scavenger effects (Abdullaev & Ferenkel 1992; Abdullaev 1993; Escribano
et al 1996; Rios et al 1996), and learning and memory improving properties (Zhang et al 1994).
Saffron extract also has chemopreventive and genoprotective effects and protects from
genotoxin-induced oxidative stress in mice (Nair et al 1995; Premkumar et al 2001, 2003;
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Abdullaev et al 2002). A blood pressure lowering effect (Rios
et al 1996) and relaxant effect on vascular smooth muscle
(Fatehi et al 2003) have been described also for this plant. 
Therefore, in this study, we have investigated the relaxant
effect of aqueous-ethanolic extracts from C. sativus and its
main constituent, safranal, on guinea-pig tracheal chains, and
its possible mechanisms have been examined. 
Plant and extracts 
C. sativus was collected from Torbat Heydarieh (east of Iran)
and identified by Mrs Molaei at the Herbarium of the School of
Agriculture, Mashhad University of Ferdowsi, where a voucher
specimen was preserved (Herbarium No: 143-0319-1). To pre-
pare the aqueous-ethanolic extract, 10 g chopped, dried plant
was extracted with 25 mL distilled water and 25 mL ethanol by
soxhlet apparatus. The solvent was then removed under
reduced pressure and distilled water was added so that the plant
ingredient concentration in the final extract was 10 g %. 
Measurement of safranal and crocin 
The amount of safranal and crocin in the extract was assessed
using HPLC (Schimatzue, SSPD-10AVP with ODS column). A
UV-vis detector set at a wavelength of 308nm was used for
assessing safranal, whilst for crocin the wavelength was set at
443nm. The solvent was acetonitrile:distilled water (24:76, v/v)
and the flow rate was 0.5mLmin−1. The injected volume was
25mL for the measurement of safranal and crocin. Using the
standard curve of safranal and crocin (Fluka chemical AG,
Switzerland), the presence of safranal and crocin was measured. 
Tissue preparations 
Male Dunkin-Hartley guinea-pigs (400–700 g) were killed
by a blow on the neck and tracheas were removed. Each tra-
chea was cut into 10 rings (each containing 2–3 cartilagi-
nous rings). All the rings were cut open opposite the
tracheal muscle, and sutured together to form a tracheal
chain (Holroyde 1986). Tissue was suspended in a 10-mL
organ bath (organ bath 61300, Bioscience Palmer-Washington,
Sheerness, Kent, UK) containing Krebs–Henseleit solution
of the following composition (mM): NaCl 120, NaHCO3
25, MgSO4 0.5, KH2PO4 1.2, KCl 4.72, CaCl2 2.5 and
dextrose 11. 
The Krebs solution was maintained at 37°C and gassed
with 95% O2 and 5% CO2. Tissue was suspended under an
isotonic tension of 1 g and allowed to equilibrate for at
least 1 h while it was washed with Krebs solution every
15 min. 
Protocols 
The relaxant effects of four cumulative concentrations of
aqueous-ethanolic extract (0.15, 0.30, 0.45, and 0.60 g %),
safranal (Fluka chemical AG, Switzerland) (0.15, 0.30,
0.45, and 0.60 mL 0.2 mg mL−1 solution), four cumulative
concentrations of theophylline anhydrous (Sigma Chemical
Ltd UK) (0.15, 0.30, 0.45, and 0.60 mM) as positive control,
and saline as negative control (0.6 mL) were examined. To
produce different concentrations of aqueous-ethanolic
extract, 0.15 mL 100 mg mL−1 concentrated extracts were
added to a 10-mL organ bath respectively four times. For
safranal 0.15 mL 0.2 mg mL−1 solution and for theophylline
0.15 mL 10 mM solution was added to the organ bath four
times. The consecutive volumes were added to the organ
bath at 5-min intervals. 
The assessment of the relaxant effect of different solu-
tions in each experiment were carried out as follows. The
tracheal chains were first contracted with 10 mM metha-
choline. After achievement of maximum contraction, which
was obtained after 7 min, four cumulative volumes from
extract, safranal, theophylline or one volume of saline was
added to the organ bath at 5-min intervals. The effect of dif-
ferent volumes of extract, safranal, theophylline or saline on
contracted tissues was measured after exposing tissue to the
solution for 5 min. The percentage effect of each volume of
different solutions (decrease or increase of tracheal tone)
was calculated in proportion to the maximum contraction
effect induced by methacholine. A decrease in tone
was considered as a relaxant (bronchodilatory) effect and
expressed as positive percentage change in proportion to the
maximum contraction; and an increase in tone was consid-
ered as a contractile (bronchoconstrictory) effect, which was
expressed as negative percentage change (Martin et al
1994). 
The relaxant effect of different solutions was tested with
three different experimental designs (n = 6 for each group)
as follows. Group 1: on tracheal chains contracted by
10 mM methacholine hydrochloride (Sigma Chemical Ltd,
UK). Group 2: on non-incubated tracheal chains con-
tracted by 60 mM KCl. Group 3: on tracheal chains incu-
bated with 1 mM propranolol hydrochloride (Sigma
Chemical Ltd, UK), 1 mM chlorpheniramine maleate
(Sigma Chemical Ltd, UK) and 1 mM atropine sulfate
(Sigma Chemical Ltd, UK) 30 min before beginning and
during the testing relaxation of different solutions; in this
series of experiments, tracheal chains were also contracted
by 60 mM KCl. 
The relaxant effect of theophylline and safranal was
examined on groups 1 and 2 only. The relaxant effects in the
three groups of experiments were examined in three differ-
ent series of tracheal chains. All of the experiments were
performed randomly with a 1 h resting period of tracheal
chains between each two experiments, while washing the
tissues every 15 min with Krebs solution. In all experiments
responses were recorded on a kymograph (ET8 G-Boulitt,
Paris) and were measured after fixation. The study was
approved by the ethical committee of Mashhad University
of Medical Sciences. 
Statistical analysis 
Data were expressed as mean ± s.e.m. Data of relaxant effects
of different concentrations of extract and safranal were com-
pared with the results of negative and positive control using
analysis of variance. The data of relaxant effect between three
Materials and Methods 
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groups were compared using analysis of variance. The relax-
ant effects of extract, safranal and theophylline were related
to the concentrations using least square regression. Signifi-
cance was accepted at P < 0.05. 
Measurement of safranal and crocin 
The amounts of safranal and crocin in the extract of C. sativus
were 0.026 and 41.3%, respectively. 
Relaxant (bronchodilatory) effect 
In group 1, all concentrations of theophylline, extract and
safranal showed significant relaxant effects compared with
those of saline (P < 0.05 to P < 0.001). The effect of the high-
est concentration of safranal was significantly lower than
those of theophylline (P < 0.05). In addition the effects of the
two higher concentrations of safranal were significantly
lower than that of extract in this group (P < 0.05 to P < 0.01)
(Table 1). 
In group 2, extract from C. sativus, safranal and theo-
phylline showed relatively potent and concentration-
dependent relaxant effects on tracheal chains of guinea-pig.
The relaxant effects of all concentrations of extract, safranal
and theophylline were significantly higher than those of
saline (P < 0.05 to P < 0.001). Only the two low concentra-
tions of safranal did not show significant relaxant effects
(Table 2). However, the effects of all concentrations of
safranal in group 2 were significantly lower compared with
theophylline (P < 0.05 to P < 0.001) (Table 2). In addition,
the effect of the two higher concentrations of safranal were
significantly lower than those of extract (P < 0.01 for both
cases). 
In group 3, the extract of C. sativus showed relatively
weak relaxant effect, and only the last extract concentration
(0.60 g %) was significantly different compared with the
effect of saline (Table 3). 
Comparison of the relaxant effect between the 
three experimental groups 
The relaxant effects of different concentrations of C. sativus
extract and theophylline were not statistically different
between groups 1 and 2. The relaxant effects of most con-
centrations of extract in groups 1 and 2 were significantly
higher than those of group 3 (P < 0.05 to P < 0.001) (Figure 1).
In addition, the relaxant effects of most concentrations of
safranal in group 2 were statistically lower than those of
group 1, except for the highest concentrations (P < 0.05 to
P < 0.01) (Figure 1). 
Correlation between concentrations of solutions 
and their relaxant effects 
There were significant positive correlations between concen-
trations of the solutions with the relaxant effects of aqueous-
ethanolic extract (0.927, 0.832 and 0.711 for groups 1, 2 and
3, respectively), safranal (0.728 and 0.782 for groups 1 and 2)
Results 
Table 1 Relaxant effect of aqueous-ethanolic extract from Crocus sativus and safranal in comparison with negative control (saline) and positive
control (theophylline) in group 1 experiments (contracted tracheal chains with 10 mM methacholine, n = 6) 
Values are presented as mean ± s.e.m. of percentage change in proportion to the maximum contraction induced by 10 mM methacholine. The unit of
concentration for extract was g %, for safranal volume (mL) of 0.2 mg mL−1 solution, and for theophylline mM. For saline only one volume (0.6 mL)
was used. *P < 0.05, **P < 0.01, ***P < 0.001 compared with saline; †P < 0.05, compared with theophylline; ‡P < 0.05, P < 0.01 compared with
safranal.
Different concn Saline Aqueous-ethanolic extract Safranal Theophylline 
0.15 – 14.51 ± 1.51* 15.47 ± 4.51* 26.59 ± 6.35** 
0.30 – 52.90 ± 6.16*** 37.49 ± 8.43*** 57.56 ± 6.85*** 
0.45 – 82.70 ± 5.00***† 48.63 ± 9.50*** 73.59 ± 7.09*** 
0.60 1.45 ± 0.51 96.97 ± 4.23***‡‡ 58.11 ± 9.50***† 87.40 ± 6.22*** 
Table 2 Relaxant effect of aqueous-ethanolic extract from Crocus sativus and safranal in comparison with negative control (saline) and positive
control (theophylline) in group 2 experiments (non-incubated preparation contracted by 60 mM KCl, n = 6) 
Values are presented as mean ± s.e.m. The unit of concentration for extract was g %, for safranal volume (mL) of 0.2 mg mL−1 solution, and for theo-
phylline mM. For saline only one volume (0.6 mL) was used. *P < 0.05, ***P < 0.001 compared with saline; †P < 0.05, ††P < 0.001 compared with
theophylline; ‡‡P < 0.01 compared with safranal. 
Different concn Saline Aqueous-ethanolic extract Safranal Theophylline 
0.15 – 14.11 ± 5.89* 4.45 ± 1.70† 18.91 ± 1.86* 
0.30 – 44.95 ± 9.78*** 11.01 ± 2.51†† 52.36 ± 2.20*** 
0.45 – 67.72 ± 10.75***‡‡ 25.64 ± 4.74*†† 70.13 ± 0.78*** 
0.60 1.02 ± 0.52 86. 61 ± 9.80***‡‡ 37.54 ± 8.64*†† 83.70 ± 1.09*** 
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and theophylline (0.815 and 0.927 for groups 1 and 2)
(P < 0.001 for all cases). 
In this study, the relaxant (bronchodilatory) effects of aqueous-
ethanolic extract from C. sativus and safranal in comparison
with saline (as negative control) and theophylline (as positive
control) were studied. In group 1 (contracted tracheal chains
by methacholine) all concentrations of theophylline extract
and safranal showed potent relaxant effect on tracheal smooth
muscle. In addition, extract from C. sativus and safranal
showed relatively potent relaxant effects compared with the
effect of saline in group 2 (contracted tracheal chains by
KCl). In group 3, the extract of C. sativus showed a relatively
weak relaxant effect compared with saline. The effects of the-
ophylline and safranal were not examined in group 3 experi-
ments. 
The relaxant effect of extract, safranal and theophylline
was concentration dependent. There were positive correla-
tions between increasing concentrations and the relaxant
effects of extract and safranal in all three groups of experi-
ments. The relaxant effects of all concentrations of safranal
were lower than those of the extract in groups 1 and 2. In
addition, the effects of extract in group 1 and 2 experiments
were similar to the effect of theophylline, but the effects of
safranal were lower compared with theophylline. 
The relaxant effect of extract from C. sativus and safranal
on guinea-pig tracheal chains might have been produced due
to several different mechanisms, including stimulation of b-
adrenergic receptors, inhibition of histamine H1-receptors or
an anticholinergic property of the plant, because the relaxant
effect of b2-stimulatory (Linden et al 1993; Martin et al 1994),
histamine H1-receptor inhibitory (Popa et al 1984), and anti-
cholinergic drugs (Loenders et al 1992) have been shown. To
evaluate the contribution of b-adrenergic stimulatory, anti-
cholinergic and/or H1 histamine blocking effect of the aque-
ous-ethanolic extract from this plant on its bronchodilatory
effects, the effects of these extracts on tracheal chains
with inhibited b-adrenergic, muscarinic and histamine H1
receptors by propranolol, atropine and chlorpheniramine,
Discussion 
Table 3 Relaxant effects of aqueous-ethanolic extract from Crocus
sativus in comparison with a negative control (saline) and a positive con-
trol (theophylline) in group 3 experiments (incubated preparations with
1 mM propranolol, 1 mM cholorpheniramine and 1 mM atropine contracted
by 60 mM KCl, n = 6) 
Values are presented as mean ± s.e.m. The unit of concentration for
extract was g %. For saline only one volume (0.6 mL) was used.
*P < 0.05 compared with the effect of saline.
Different concn Saline Aqueous-ethanolic 
extract 
0.15 – 1.84 ± 1.29 
0.30 – 8.71 ± 3.60 
0.45 – 17.96 ± 5.52 
0.60 1.23 ± 0.62 26.48 ± 6.55* 
Drug concn
A
B
C
Methacholine-induced
contraction (incubated)
Methacholine-induced
contraction (non-incubated) 
KCl-induced contraction
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Figure 1 Concentration–response curves of the relaxant effect of (A)
theophylline, (B) aqueous-ethanolic extract from Crocus sativus, and (C)
safranal, in three groups of experiments. Group 1, methacholine-induced
contraction on non-incubated tracheal chains (); group 2, KCl-induced
contraction on non-incubated tracheal chains (); and group 3, KCl-
induced contraction on guinea-pig tracheal chains incubated with pro-
pranolol, chlorpheniramine and atropine () (n = 6 for each group). The
unit of concentration for the extract was g %, for safranal volume (mL) of
0.2 mg mL−1 solution and for theophylline mM. *P < 0.05, **P < 0.01,
statistical differences in the relaxant effect of different substances
between groups 1 group 2. +P < 0.05, ++P < 0.01, +++P < 0.001, statist-
ical differences in the relaxant effect of different substances between
groups 1 and 2 with those of group 3.
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respectively, were re-examined in group 3 experiments. The
plant extract showed a weak relaxant effect in group 3
experiments. The relaxant effects of most concentrations of
C. sativus-extract obtained in group 3 were significantly
lower than those of group 2. These findings suggested prob-
able b-adrenergic stimulatory, muscarinic and/or histamine
H1 blocking properties of the plant extract that may have
contributed to the relaxant effect on guinea-pig tracheal
chains. The enhanced relaxant effect of extract at higher
concentrations, and positive correlation between its effect
and concentration supported the competitive antagonist
effect of the extract on muscarinic or histamine H1 receptors
and/or stimulatory effect on b-adrenoceptors. However, the
most probable mechanism responsible for the relaxant effect
of C. sativus on the tracheal chains was the stimulatory
effect on b-adrenoceptors, because b-agonists to drugs are
the most powerful bronchodilators. 
While KCl affects calcium channels (Perez-Guerrero et al
1997) and with regard to the bronchodilatory effect of cal-
cium-channel blockers (Miyahara et al 1993; McCaig &
DeJonckeere 1993), the relaxant effect of C. sativus extract
and safranal in group 2 (contracted tracheal chains by KCl)
may have indicated a calcium-channel blocking effect of this
plant and safranal. Another explanation for these findings
was the absence of an opening effect of this plant and its main
constituent safranal on potassium channels, because the bron-
chodilatory effect of potassium-channel opening drugs has
been demonstrated previously (Buckle et al 1993). If the
extract had a potassium-channel opening effect, it would not
have relaxant effects on KCl-contracted tracheal chains,
while it could show a relaxant effect on methacholine-con-
tracted tracheal chains. In fact, the results of group 2 may
support this effect of macerated extract. 
The results of this study confirmed those of Fatehi et al
(2003), indicating a relaxant effect of this plant on smooth
muscles of the vascular system. However, in this study some
mechanisms responsible for the relaxant effect of the plant,
including b-adrenoceptor stimulatory, muscarinic or hista-
mine H1 inhibitory, calcium-channel inhibitory and potas-
sium-channel opening effects, were explored. 
The relaxant effect of safranal in groups 1 and 2 indicated
that it was one of the main constituents of the plant respons-
ible for the relaxant effect. However, the significant lower
relaxant effect of safranal compared with extract on both
groups of experiments suggested that other constituents of the
plant might have contributed to the relaxant effect. Therefore,
more studies are required to reveal the effective substances
and extract mechanisms of action for the relaxant effect of C.
sativus. The HPLC results showed that the extract contained
only 0.026% safranal, while the amount of crocin in the
extract was 41.3%. This suggests that the relaxant effect of
crocin should be evaluated further. 
With regard to the existence of airway inflammation in the
tracheobronchial tree of asthmatic patients, C. sativus might
have an anti-inflammatory effect, which would contribute to
the therapeutic effect of this plant on asthma. In fact, the anti-
inflammatory (Abe et al 1999) and antioxidant (Abdullaev
1993) effects of this plant have been shown. However, the
effect of C. sativus on airway inflammation existing in
asthma and other respiratory disease requires investigating. 
Conclusion 
The results indicated a relatively potent relaxant effect (bron-
chodilatory) of C. sativus on guinea-pig tracheal chains,
which was comparable with theophylline. The results sug-
gested that the relaxant effect of this plant could be due to
b-adrenoceptor stimulatory, muscarinic and/or histamine (H1)
receptor inhibitory effect. A possible inhibitory effect of
aqueous-ethanolic extract on calcium channels has been pos-
tulated. The results suggested that the safranal was, at least in
part, responsible for the relaxant effect of the plant on
tracheal chains. 
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